ArticleTheranostics2026

OSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer.

Qihui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.